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Abstract 
Streptococcus suis (S. suis) is an important swine pathogen and an emerging zoonotic agent. Most clinical S. suis strains 
express capsular polysaccharides (CPS), which can be typed by antisera using the coagglutination test. In this study, 
79 S. suis strains recovered from diseased pigs in Canada and which could not be typed using antisera were further 
characterized by capsular gene typing and sequencing. Four patterns of cps locus were observed: (1) fifteen strains 
were grouped into previously reported serotypes but presented several mutations in their cps loci, when compared 
to available data from reference strains; (2) seven strains presented a complete deletion of the cps locus, which would 
result in an inability to synthesize capsule; (3) forty-seven strains were classified in recently described novel cps loci 
(NCLs); and (4) ten strains carried novel NCLs not previously described. Different virulence gene profiles (based on the 
presence of mrp, epf, and/or sly) were observed in these non-serotypeable strains. This study provides further insight 
in understanding the genetic characteristics of cps loci in non-serotypeable S. suis strains recovered from diseased ani-
mals. When using a combination of the previously described 35 serotypes and the complete NCL system, the number 
of untypeable strains recovered from diseased animals in Canada would be significantly reduced.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Streptococcus suis is recognized as one of the most 
important causes of bacterial disease in post-weaned pig-
lets worldwide, generating important economic losses to 
the swine industry. In addition, it is an important emerg-
ing zoonotic agent [1–3]. Clinical strains of S. suis gen-
erally have a capsule (capsular polysaccharide or CPS), 
which is the basis of the serotyping traditionally used for 
epidemiological studies. Thirty-five serotypes of S. suis 
(serotype 1 through 34 and serotype 1/2) were identified 
in the 1980s and the 1990s [4–7]. More recently, sero-
types 20, 22, 26, 32, 33 and 34 have been suggested as 
belonging to a species different from S. suis [8, 9]. Strains 
isolated from diseased pigs primarily belong to serotype 
2 in most countries, followed by serotypes 3, 4, 5, 7, 8 
and 1/2 [10–12]. In some European countries, serotype 
9 is also one of the most frequently recovered capsular 
types from diseased animals [12, 13]. Traditionally, S. suis 
is routinely serotyped by the coagglutination test using 
serotype-specific antisera. However, non-serotypeable S. 
suis strains are frequently reported in many studies [12, 
14–18]. Given that strains not expressing the CPS can-
not be serotyped using antisera, serotyping based on 
molecular techniques has been proposed. Since the S. 
suis CPS is synthesized by the Wzx/Wzy pathway in the 
CPS locus, wzy genes have been demonstrated to be sero-
type-specific [19]. Thus, high-throughput capsular gene 
typing systems based on serotype-specific wzy genes have 
become attractive alternatives/complement to the exist-
ing serological tests [18, 20, 21]. However, even with the 
Open Access
*Correspondence:  marcelo.gottschalk@umontreal.ca 
†Han Zheng and Xiaotong Qiu contributed equally to this work 
2 Faculty of Veterinary Medicine, Swine and Poultry Infectious Diseases 
Research Center, University of Montreal, Quebec, Canada
Full list of author information is available at the end of the article
Page 2 of 10Zheng et al. Vet Res  (2017) 48:10 
use of multiplex PCR tests, non-serotypeable strains are 
still commonly isolated from both clinically healthy and 
diseased animals [18, 22, 23].
In recent years, 17 novel cps loci (NCLs) were identi-
fied from non-serotypeable S. suis and were designated 
as NCL1 to 16 and serotype Chz [22–24]. Meanwhile, 
an 18-plex Luminex assay was also developed to detect 
these 17 NCLs and nearly 60% of non-serotypeable 
strains from healthy pigs carried one of these NCLs [22]. 
However, little is known about the distribution and char-
acteristics of the cps loci of potentially virulent non-sero-
typeable strains recovered from diseased animals.
In this study, the cps loci of 79 Canadian non-sero-
typeable S. suis strains (as determined by the coaggluti-
nation test) recovered from diseased pigs were studied 
using two capsular gene typing systems [20, 22] and the 
genetic characteristics of the NCLs were analyzed. To 
elucidate the non-serotypeable mechanisms of strains 
grouped into previously described serotypes, the study 
was extended to compare their cps sequence to that of 
corresponding reference strains. Furthermore, the preva-
lence of minimum core genome (MCG) sequence typing 
group and virulence gene profile were also investigated in 
all 79 strains.
Materials and methods
Bacterial strains and chromosomal DNA preparation
A total of 79 S. suis strains isolated from diseased pigs 
on non-related farms in Canada were used in this study 
(Additional file 1). All strains have been isolated from pri-
mary affected organs of clinically diseased pigs, including 
brain (meningitis; n = 18), heart (endocarditis; n = 18), 
multiple organs (septicemia; n = 14), pleura (polyserosi-
tis; n = 9), lungs (pneumonia; n = 9) and joints (arthri-
tis; n =  1). For a very few isolates, the information was 
not available, but they were all recovered from diseased 
animals with a primary diagnosis of S. suis infection. All 
isolates were serotyped using the coagglutination test 
[25]. Chromosomal DNA was prepared from all strains as 
previously described [21]. The species identity of the 79 
strains was determined to be S. suis by amplification of 
the 16S rRNA, recN, gdh, and thrA genes [20, 26–28].
Capsular gene typing
The cps locus type of the 79 strains was identified by the 
32-plex and 18-plex Luminex assays previously reported 
[20, 22]. The subtypes of known NCLs were determined 
based on the arrangement of subtype-specific homology 
groups (HGs) and transposases [22, 23].
Sequencing cps loci and bioinformatics analyses
Seventeen strains which could not be grouped using 
the 32- and 18-plex Luminex assays and 3 strains which 
could not be grouped into known subtypes, as well as 
15 strains which were grouped into reference serotypes, 
were sequenced by Illumina sequencing as previously 
described [23]. Each cps locus sequence was extracted 
from the draft genome sequence and was analyzed 
using the same bioinformatics methods described in 
previous studies [19, 22, 23]. The products of the cps 
genes were assigned to novel HGs if both of the global 
match regions and identity of the amino acid or nucleo-
tide sequences were below 50% when compared to the 
420 currently known HGs of the 35 reference serotypes 
and 17 NCLs. The novel HGs were assigned numerical 
values from HG421 onwards [19, 22, 23]. Novel HGs 
that were present in all strains of a given NCL were 
identified as NCL-specific HGs. The strains harboring 
the same wzy were clustered into the same NCL. The 
Artemis comparison tool (ACT) was used to visualize 
the data [29].
MCG typing and PCR assays for mrp (muramidase released 
protein), sly (suilysin) and epf (extracellular protein)
MCG sequence typing was performed using PCR ampli-
fication and DNA sequencing as previously described 
[30, 31]. The full-length mrp gene was amplified and 
sequenced using a previously described method [11]. 
Amplification of the sly and epf genes was performed 
according to methods previously described [32, 33].
Nucleotide sequence accession number
Sequences of cps loci obtained in this study were depos-
ited in GenBank under the accession numbers KX870047–
KX870056, KX870058–KX870064, KX870067–KX870072, 
and KX870074–KX870076. Reads of the sequenced strains 
were deposited in GenBank under accession number 
SRR5177663–SRR5177696 and SRR5177711. All accession 
numbers can also be found in Additional file 1.
Results
Serotyping of strains
The 79 strains used in the present study showed auto-
agglutination, poly-agglutination or non-agglutination 
using the reference antisera and the coagglutination 
test and were thus considered as non-serotypeable. All 
strains were then typed using our previously developed 
capsular gene typing systems [20, 22]. Fifteen strains 
(18.9%) were grouped into reference serotypes while 
47 (59.4%) were grouped into 17 known NCLs. The 
remaining 17 strains remained non-typeable (Addi-
tional file 1).
Of the 15 strains belonging to the previously described 
serotypes, serotype 2 or 1/2 (n  =  4), which cannot be 
distinguished by capsular gene typing, was the most fre-
quent, followed by serotypes 15 (n = 3), 11 (n = 2), and 
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30 (n = 2). Serotypes 5, 17, 27 and 29 only contained a 
single strain (Additional file 1).
Of the 47 strains which were assigned to previously 
known NCLs, NCL3 (n  =  18) was the most prevalent, 
followed by NCL4 (n = 8), NCL7 (n = 4), NCL2 (n = 3), 
NCL12 (n  =  3), and NCL13 (n  =  3). In addition, one 
strain each of the NCL1, 5, 6, 10, 11, 14, 16, and Chz were 
also found (Additional file 1).
Identification of four new NCLs
The remaining 17 non-serotypeable strains mentioned 
above were sequenced by Illumina sequencing. The 
cps locus was absent from 7 strains. The cps loci of the 
remaining 10 strains were divided into four new NCLs 
which were named NCL17 to 20 based on their wzy gene 
sequences. NCL17 was the most prevalent (n =  4), fol-
lowed by NCL18 (n  =  3), NCL19 (n  =  2), and NCL20 
(n = 1) (Additional file 1). In addition, two types of pat-
terns were found in the four new NCLs. NCL17 and 
NCL18 belonged to pattern I-a, while NCL19 and NCL20 
belonged to pattern I-b [19].
The sizes of these NCLs ranged from 21.34 to 29.90 kb 
and the percentage of G+C content varied between 33.9 
and 35.1%. Fifty-nine predicted coding sequences were 
designated cps HGs. Twenty-two HGs were also present 
in the cps loci of the reference strains of known serotypes 
and 17 known NCLs. An initial sugar transferase gene 
was located in the 5′ region and was classified into three 
HGs: HG6 (NCL20), HG8 (NCL17), and HG295 (NCL18 
and NCL19). The 5′ regions of four NCLs were con-
served, whereas the central and 3′ regions of these were 
highly variable (Figure 1A).
Thirty-two HGs were NCL-specific. Each NCL con-
tained 4–11 NCL-specific genes, with 4 HGs for NCL17, 
7 HGs for NCL18, 11 HGs for NCL19, and 10 HGs for 
NCL20. Among these, 11 HGs encoded putative glyco-
syl transferases and two encoded acetyltransferases. As 
expected, all Wzy polymerases and Wzx flippases were 
NCL-specific (Additional file 2).
Determining the subtypes of NCLs
NCL2, NCL3, NCL7, and NCL11 strains were found to 
belong to a single subtype; NCL2-4, NCL3-1, NCL7-1, 
and NCL11-5, respectively. Genetic heterogeneity was 
not found within strains of NCL12, NCL15, and NCL17 
to 20 (Additional file 2).
i. NCL1: strain 1640373 could not be classified into any 
known NCL1 subtype and was sequenced by Illu-
mina sequencing, named as NCL1-12. The replace-
ment of HG293, HG294, and HG292 by the HG354 
and HG355 was found in its three side regions (Fig-
ure 1B).
ii. Chz: compared to the reference strain Chz-2, the 
deletion of HG55 was found in strain 1232225, 
named as Chz-3 (Figure 1C).
iii. NCL16: compared to the reference strain YS525 
(NCL16-1), the insertion of HG55 was found in 
strain 1093407, named NCL16-3 (Figure 1D).
Mutations in the cps loci of strains belonging to previously 
described serotypes
The 15 strains that were negative by coagglutination test 
but positive by multiplex Luminex assay for the refer-
ence serotypes were further analyzed. Comparing to the 
cps locus of the corresponding serotype reference strains, 
insertions and deletions were found in the serotype 5, 
11, 15, 17 and 30 strains. The cps loci of four serotype 2 
or 1/2 strains and one serotype 27 strain were intact and 
small-scale mutations were detected in these (Table 2).
i. Serotype 2 or 1/2: compared to the serotype 2 ref-
erence strain P1/7 (GenBank accession number 
BR001000), all four strains had a 33 bp insertion in 
wxy genes and four strains had single-nucleotide 
substitutions in wzx genes. The single-nucleotide 
substitutions in glycosyltransferase genes and a 
27  bp deletion in the side-chain formation gene 
were also found in five strains (Table 2).
ii. Serotype 5: compared to the serotype 5 refer-
ence strain 11538 (GenBank accession number 
BR001003), the deletions of HG17 to HG19 at the 
3′ end were found in strain 1218846 (Figure 2A).
iii. Serotype 11: compared to the serotype 11 refer-
ence strain 12814 (GenBank accession number 
AB737819), HG72 and HG73 were replaced by 
HG32 and HG40 in strains 1336897 and 1336915. 
In addition, the nucleotide substitutions (TA→CC) 
of the termination codon of HG32 were found in 
the cpsQ gene of strains 1336897 and 1336915, 
which resulted in the chimeric HG32/HG39 gene 
(Figure 2B).
iv. Serotype 15: two types of variations were found 
within this serotype. Strains 1424566 and 1449343 
possessed identical cps sequences. A novel HG 
(cpsH, putative acetyltransferase) was inserted 
between HG33 and HG77, and the insertions of 
HG19 and HG17 at the 3′ end were found in two 
strains (Table 1). Moreover, the transversion (T→G) 
was found at the site of the termination codon of 
HG19, which resulted in the chimeric HG18/HG19 
gene in two strains. Compared to strains 1424566 
and 1449343, HG18 and HG17 were replaced by a 
transposase in strain 1761402 (Figure 2C).
v. Serotype 17: compared to the serotype 17 refer-
ence strain 93A (GenBank accession number 
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AB737824), two deletions (HG21 and HG161) and 
two insertions (HG354 and HG355) were found. 
Furthermore, HG79 and HG80 were replaced by 
a putative phosphotransferase, a putative hypo-
thetical protein, a putative biotin carboxylase, 
and a putative glycosyltransferase (initial sugar 
transferase), which were not assigned to any pre-
vious homology group (Table  1). Moreover, the 
replacement of HG48, HG17, HG18, and HG19 by 
HG293, HG294, and HG292 was also found (Fig-
ure 2D).
vi. Serotype 27: compared to the serotype 27 refer-
ence strain 89–5259 (GenBank accession number 
AB737831), the single-nucleotide substitutions and 
small-scale indels in glycosyltransferase genes, wzx 
gene, and side-chain formation gene were found 
(Table 2).
Figure 1 Comparison of the cps loci among NCL17 to 20 (A) and within NCL1 (B), Chz (C) and NCL16 (D). Each colored arrow represents 
the gene whose predicted function is shown in the below panel. NCL-specific genes are indicated by dotted blue lines.
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vii. Serotype 29: compared to strain YS54 agglutinated 
with both serotypes 21 and 29 antisera (GenBank 
accession number KC537387), the insertions of 
a transposase gene, HG293, HG294, and HG292 
on the 3′-side were found in strain 1127863 (Fig-
ure 2E).
viii. Serotype 30: compared to the serotype 30 refer-
ence strain 92–1400 (GenBank accession number 
Figure 2 Comparison of the cps loci within serotype 5 (A), serotype 11 (B), serotype 15 (C), serotype 17 (D), serotype 21/29 (E) and 
Chz (F). Each colored arrow represents the gene whose predicted function is shown in the below panel.
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AB737834), insertion of HG9 was found in strains 
1611502 and 1839679. Moreover, HG72, trans-
posase gene, and HG73 were replaced by HG17, 
HG18, and HG19 (Figure 2F).
Variations of chromosomal loci
In a previous study, the chromosomal loci of cps gene clus-
ters of reference serotype 5 and 17 strains were classified 
into pattern I-a [19]. In the present study, strains 1218846 
(serotype 5) and 1224887 (serotype 17) were classified into 
pattern I-b (Figures 2A and D, respectively).
MCG typing
The majority of the 79 strains were clustered in the MCG 
group 6 (44.3%, 35/79 strains), followed by ungroupable 
(24%, 19/79 strains), and group 7 (20.2%, 16/79 strains). 
MCG groups 4, 3, 2, and 1 also contained four, three, one, 
and one strains, respectively (Additional file 1).
Identifying genotypes of mrp, epf, and sly
Twelve strains were mrp positive. Frameshift mutations 
at 2740 bp from the reported initiator ATG codon were 
present in the mrp gene of strain 1114193, which resulted 
in premature stop codons. Eleven other strains contained 
intact full-length mrp gene copies and may express MRP. 
Based on the mrp subtypes reported in North America 
(NA) [11], the sequences of mrp were grouped into one 
of three subtypes, EU (European, n =  3), NA1 (n =  7), 
or NA2 (n  =  1). Only twelve strains contained the sly 
gene and 6 strains were positive for epf. There were 
eight genotypes of mrp, epf, and sly, primarily based on 
mrp variation: most of the strains in this study (n = 62) 
were mrp−sly−epf−, followed by mrpNA1sly−epf− (n = 4), 
mrpNA1sly+epf− (n = 4), and mrpEUsly+epf+ (n = 3). It is 
noteworthy that the latter strains were serotype 2 or 1/2, 
serotype 15 and serotype 30, as revealed by the 32-plex 
Luminex assay. In addition, mrp−sly+epf+ (n  =  2), 
mrp−sly+epf− (n  =  2), mrpNA2sly+epf− (n  =  1), and 
mrp−sly−epf + (n = 1) genotypes were also found (Addi-
tional file 1).
Discussion
In addition to the traditional 35 serotypes originally 
described for S. suis, 17 NCLs have recently been 
reported in non-serotypeable S. suis strains isolated from 
healthy animals using high-throughput typing systems 
and online bioinformatics [22, 23]. However, the genetic 
characteristics of cps loci in potentially virulent non-
serotypeable S. suis strains recovered from diseased ani-
mals are still scarce.
In the present study, the cps loci of 79 Canadian non-
serotypeable strains isolated from the internal organs of 
diseased pigs were analyzed. Non-serotypeable strains are 
frequently isolated from diseased animals in this coun-
try [34]. Based on previous gene typing and sequencing 
results [22, 35], the non-serotypeable phenotype may be 
attributed to one of three causes: (1) strains belonging to 
previously described serotypes harboring mutated cps 
loci causing loss of capsule expression or antigenic varia-
tion; (2) strains without cps locus completely losing their 
ability to synthesize capsule; or (3) strains with not-previ-
ously described NCL referring to novel serotypes.
In this study, 15 non-serotypeable strains could be 
grouped into reference serotypes by the 32-plex Luminex 
assay. To elucidate the lack of positive identification by 
the coagglutination test, we further sequenced and com-
pared their cps loci to those of corresponding reference 
strains. Previous studies showed that replacements and 
large indels, as well as small-scale mutations of cps genes, 
caused phenotypical changes in agglutination tests [21, 
Table 1 Information of the novel HGs inserted cps loci of strains belonging to reference serotypes



















cpsJ Biotin carboxylase Biotin carboxylase, Ruminococ-
cus sp. (CBL19829.1)
99/60
cpsK Glycosyltransferase Glycosyltransferase family 
1 protein, Gallibacterium 
anatis (WP_065231950.1)
92/58
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Table 2 Mutations in glycosyltransferase, side-chain formation, wzy and wzx genes of serotype 2 or 1/2 representative 
strains and a serotype 27 strain
Strain Affected gene(s) Types of mutations Affected nucleotide(s) [Affected amino acid]
1827702 cps2E Missense A61G [Thr21Ala]
cps2I Insertion IS element: 33 bp
cps2N Deletion 27 bp
1090772 cps2E Missense A61G [Thr21Ala]
cps2F Missense A149G [Asp50Gly]
Missense A1047T [Leu349Phe]
cps2I Insertion IS element: 33 bp
cps2N Deletion 27 bp
cps2O Missense C859A [Arg287Ser]




Missense A524T A525T [Lys175Ile]
Missense A541C C543G [Ile181Leu]
Missense A553G [Ile185Val]
Missense G617T T618G [Ser206Met]
Missense A623T [Tyr208Phe]
Missense T633G [Leu211Val]
Missense C640T A642C [Leu214Phe]
Missense A651T [Glu217Asp]
Missense C692T [Ser231Leu]
Missense G706A A708G [Ala236Thr]
Missense G874A A876T [Val292Ile]
Missense T905C [Val302Ala]
Missense A922C A924G [Lys308Gln]
Missense A941C G942A [Lys314Thr]
Missense A967G [Ile323Val]
Missense A997C G999C [Met333Leu]
Missense G1000A C1001G T1002C [Ala334Ser]
Missense A1174C A1175G [Lys392Arg]
Missense G1186A G1187T T1188G [Gly396Met]
Missense A1272C [Glu424Asp]
Missense A1279C A1280G [Lys427Arg]
Missense G1288T T1290A [Val430Leu]
Missense A1292C [Glu431Ala]
Missense G1324A A1326T [Val442Ile]
Missense A1357T T1359G [Ile453Leu]
Missense A1360T A1361T [Lys454Leu]
cps27F Deletion 27 bp
Missense A662T [His221Leu]
cps27G Insertion IS element: 21 bp
cps27I Missense G483C [Trp161Cys]
Missense C513A [Asp171Glu]
Missense A611G [Gln204Arg]
cps27L Deletion 57 bp
cps27M Missense C1373T C1374T [Ala458Val]
Missense C1375T [Leu459Phe]
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36–38]. We also found similar mutations in the cps loci 
of strains tested.
HG17, HG18, HG19, HG32, HG39, and HG40, which 
were present in the cps loci of the reference strains 
belonging to serotypes 1, 2, 4, 5, 7, 14, 17, 18, 19, 23 and 
1/2, were detected in the cps loci of strains in the pre-
sent study belonging to serotypes 11, 15, and 30. Moreo-
ver, chimeric HG18/HG19 and HG32/HG39 genes were 
found in serotype 11 and 15 strains. It is noteworthy that 
HG292, HG293, HG294, HG354, and HG355, only pre-
sent in the cps loci of NCLs, were also detected in the cps 
locus of strain 1224889, typed herein as serotype 17. In 
addition, some genes which were never before assigned 
to any HG were found to be inserted in the cps loci of 
strains belonging to serotypes 17 and 15. The sequence 
differences between strains NCL8-2 and 1127863 were 
mainly caused by the replacement of 8 NCL-specific HGs 
in the center of NCL8-2 and by 6 HGs in 1127863. The 
replacement and insertion activities may indicate recom-
bination events or horizontal gene  transfer between the 
cps loci of S. suis strains, probably leading to antigenic 
variations that would be beneficial to S. suis in the course 
of infection or through immunity evasion.
Comparing to the cps loci of their corresponding ref-
erence strains, only small-scale mutations were observed 
in four strains typed as serotype 2 or 1/2 by the 32-plex 
Luminex. Previous study revealed that all serotype 2 and 
all serotype 14 strains had a G nucleotide at position 483 
of the cpsK gene, while all serotype 1 and all serotype 1/2 
strains (including 13 serotype 1/2 strains recovered in 
Canada) contained either a C or T at that nucleotide posi-
tion [39]. In present study, all four strains had a G nucleo-
tide at position 483 of the cpsK gene. We postulated that 
they were most probably non-encapsulated serotype 2 
strains. A previous study reported that single-nucleotide 
substitutions and frameshift mutations in two glycosyl-
transferase genes (cps2E and cps2F) were the main causes 
of capsule loss in serotype 2 strains. Moreover, mutations 
in the genes involved in side-chain formation (cps2J and 
cps2N), wzy (cps2I), and wzx (cps2O) also appeared to be 
lethal to serotype 2 strains [36]. It may be hypothesized 
that the missense mutations and small scale indels found 
in these genes in strains of the present study also had a 
deleterious effect on the capsular expression. Indeed, 
high hydrophobic indexes have been obtained with these 
strains (unpublished data), which strongly suggest lack of 
capsule expression [15, 40]. Although non-encapsulated 
S. suis strains had originally been considered to be aviru-
lent, they are frequently isolated from cases of endocar-
ditis; as such, non-encapsulation could be, under certain 
circumstances, beneficial for S. suis in the course of such 
infections [36, 41]. In some cases, non-encapsulated 
strains resulting from small point mutations may switch 
to a capsulated phenotype in  vivo [42]. Interestingly, 
small-scale mutations or clear deletions of cps loci were 
also found in an additional eight strains, which are also 
probably non-encapsulated. Finally, strains without cps 
locus completely losing their ability to synthesize cap-
sule were also found in this study. It is possible that these 
strains are not able to reverse the encapsulated pheno-
type. The biological and pathological significance of these 
non-encapsulated strains need to be further evaluated. 
Although never described, it is not impossible that some 
strains lose the capsular phenotype after in vitro culture.
In this study, 60% of non-serotypeable strains carried 
one of the recently described NCLs. The most common 
NCLs were 3, 4, 7, and 17, whereas in a previous study 
with strains recovered from healthy pigs in China, the 
most common NCLs were 1, 2, 3, and 7 [22]. Differences 
may be due to the geographical origin of strains (Can-
ada vs. China) and/or their virulence potential (strains 
from diseased or clinically healthy animals). Since many 
strains of NCL3 have been identified in this study, further 
research on its virulence potential should be performed. 
In addition, and similarly to a previous study [22], high 
diversity within the same NCL was observed. The S. suis 
species is composed of phenotypically and genetically 
diverse strains. Host specificity and ecological environ-
ment may contribute to this diversity. The cps loci could 
provide important information regarding the ecology 
of strains. The differences in dominant NCLs between 
clinical strains from Canada and field strains from China 
and the emergence of novel NCLs or subtypes in clinical 
strains from Canada are expected.
In this study, new NCLs (CNL17–20), distributed in 
10 strains, are reported for the first time. These NCLs 
possess completely different Wzy and transferases from 
those of the previously reported serotypes and NCLs, 
which in turn may express unique oligosaccharide struc-
tures and antigen identities. It is noteworthy that, taking 
into consideration all NCLs, more than 70% of non-type-
able strains could now be typed. The use of the complete 
serotyping and NCL typing system would considerably 
reduce the number of non-typeable strains recovered 
from diseased animals in Canada.
The presence of some genes, such as mrp, epf, and sly, 
has been associated with virulence [43, 44]. Three distinct 
mrp genotypes have been reported so far and NA1 was 
the dominant genotype in S. suis strains recovered from 
diseased pigs in the USA [11]. In the present study, 11 
strains possessed an intact mrp gene and NA1 genotype 
whereas three strains harbored the EU genotype. One of 
latter strains was typed as being a serotype 2 or 1/2 by the 
32-plex Luminex but, as mentioned above, it is probably 
a real serotype 2 as shown by the presence of a G nucleo-
tide at position 483 of the cpsK gene. The fact that most 
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mrp+, epf+, and sly+ Eurasian serotype 2 strains belong 
to the clonal complex 1 [12] also indicated the strain is 
most probably a non-encapsulated serotype 2 strain with 
an Eurasian profile [11] that might have been introduced 
to North America through the importation of animals. 
In fact, it has been reported that up to 5% of serotype 2 
strains recovered in the United States are ST1 and proba-
bly originated from Europe [11]. Although the most prev-
alent virulence gene profile was mrp−sly−epf −, 17 strains 
contained at least one of these three genes. The relevance 
of these virulence markers in strains of serotypes differ-
ent from serotype 2 is still controversial.
The most prevalent MCG groups amongst the strains 
harboring NCLs were the groups 6 and 7, which had 
been described as being the most ancient groups in the 
S. suis population [30]. This indicates that their cps loci 
have existed for a long time and play important roles in 
the serotype diversity of S. suis population. The most 
prevalent MCG groups amongst the strains harboring 
mutated cps loci of previously described serotypes and 
the strains losing their cps loci were MCG ungroupable. 
These strains possibly had a more significant recombi-
nation history that prevented them from being reliably 
assigned; meanwhile these recombination events may 
facility the mutations and loss of their cps loci.
In conclusion, this study provides further insight in 
understanding the cps diversity of S. suis and may con-
tribute to future epidemiological studies that will allow 
characterization of potentially virulent and previously 
non-serotypeable strains isolated from diseased animals. 
Use of the 35 serotype-based system complemented with 
the NCL typing system would significantly reduce the 
number of untypeable strains recovered from diseased 
animals in Canada. Further studies with S. suis strains 
isolated in other countries are needed.
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